MedPath

Effect of Calcium Plus Vitamin D Supplementation on Adolescent Mother and Infant Bone Health

Not Applicable
Conditions
Lactation Bone Loss
Infant Bone Growth
Interventions
Dietary Supplement: Calcium plus vitamin D
Registration Number
NCT01732328
Lead Sponsor
Universidade Federal do Rio de Janeiro
Brief Summary

Pregnancy and lactation are periods of high calcium requirement. Inadequate maternal calcium intake and vitamin D insufficiency may adversely affect fetal and neonatal growth and maternal bone mass particularly in adolescent mothers. The investigators propose to evaluate the influence of calcium plus vitamin D supplementation during pregnancy on bone mass of lactating adolescent mothers with habitually low calcium and vitamin D, on fetal growth and neonate bone mass. Mothers are randomly assigned to receive daily calcium (600 mg) plus vitamin D3 (200 IU) supplement or placebo from mid gestation until parturition. Fetal growth parameters are assessed by standard ultrasound techniques at mid and late gestation. Maternal bone mass is assessed by dual energy x-ray absorptiometry (DXA) at 2 and 5 months postpartum and 6 months after weaning. Infant bone mass is assessed by DXA at 2 months postpartum.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
76
Inclusion Criteria
  • 13-19 y old
  • between 23 and 29 wk of gestation
  • primiparous
  • carrying single fetus
  • intending to exclusively or predominantly breastfeed
Exclusion Criteria
  • chronic health problems
  • smokers
  • users of nutritional supplements, except iron supplements provided during standard prenatal care

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Calcium plus vitamin DCalcium plus vitamin D600mg of calcium and 200 international units (IU) vitamin D taken daily
Primary Outcome Measures
NameTimeMethod
Differences in maternal bone mass changes postpartum between supplemented and placebo groups2, 5 and 12 months postpartum
Differences in fetal growth and infant bone mass between supplemented and placebo groups2nd and 3rd trimester gestation and 2 mo postpartum
Secondary Outcome Measures
NameTimeMethod
Differences in changes of bone and calcium related hormones and vitamin D status between supplemented and placebo groups2nd and 3rd trimester of pregnancy and 2, 5, 12 mo postpartum
Differences in human breast milk composition (nutrients and hormones) between supplemented and placebo groups2 months postpartum
Differences in maternal bone status according to vitamin D receptor (VDR) polymorphisms2, 5 and 12 months postpartum
Differences in infant body composition between supplemented and placebo groups2 months postpartum
Differences in changes of maternal body composition postpartum between supplemented and placebo groups2, 5 and 12 months postpartum
© Copyright 2025. All Rights Reserved by MedPath